Publications
5674 Results
- Journal / Conference
- Journal of the National Cancer Institute 101(14):984-992
- Year
- 2009
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, and Lymphoma
- Study Number(s)
- SWOG-7436, SWOG-7524, SWOG-7713/14, SWOG-7823/24/25/26, SWOG-7827, SWOG-7924, SWOG-7925, SWOG-8124/25/26, SWOG-8232, SWOG-8241, SWOG-8313 (EST 5186), SWOG-8412, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8516 (INT-0067), SWOG-8591(NCI Intergroup #0035), SWOG-8600, SWOG-8738, SWOG-8812, SWOG-8994 (EST-C-0690) (INT-0086), SWOG-8997 (EST-3887) (ECOG-3887), SWOG-9031, SWOG-9308, SWOG-9509
Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328
- Journal / Conference
- Journal of Clinical Oncology 27(13):2157-2162
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814, SWOG-8897
Treatment quality and outcomes of African American versus Caucasian breast cancer patients: retrospective analysis of Southwest Oncology Group studies S8814-S8897 [PMC2674002; PMID19307504]
- Journal / Conference
- Prostate Cancer Screening, 2nd edition, D. Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, NY, Ch. 25, pp. 349-360
- Year
- 2009
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
The Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- Quality of Life Research 18:147-155
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9916
Chemotherapeutic impact on pain and global health-related quality of life in homone-refractory prostate cancer: dynamically modified outcomes analysis of a randomized controlled trial [PMC2859212; PMID19130298]
- Journal / Conference
- American Journal of Clinical Oncology 32:453-459
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0312
A phase II study of gemcitabine and capecitabine in patients with advanced renal cell cancer (RCC): Southwest Oncology Group Study S0312 [PMID 19487915;PMC3394591]
- Journal / Conference
- Journal of Urology 181(2):512-516
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8949
Predictors of survival in advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949 [PMID19100570; PMC3394523]
- Journal / Conference
- Journal of Clinical Oncology 27(34):5788-5793
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0317
A phase II study of erlotinib (OSI-774) in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317 [PMC2793000; PMID19884559]
- Journal / Conference
- Journal of Clinical Oncology 27(9):1419-1425
- Year
- 2009
- Research Committee(s)
- Gynecologic
- Study Number(s)
- G0182
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer, a phase III trial of the Gynecologic Cancer InterGroup (GCIG) [PMC2668552;PMID19224846]
- Journal / Conference
- Journal of Clinical Oncology 27(30):4973-4979
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8897
Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for breast cancer: results from an ancillary study to Southwest Oncology Group Trial S8897 (INT-0102). [PMC2799053;PMID19752340]
- Journal / Conference
- Leukemia and Lymphoma 50(5):728-735
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0108